Locations:
Search IconSearch

Trigeminal Neuralgia: A Primer on Diagnosis and Treatment (Podcast)

Pharmacologic, procedural and surgical treatments abound

Trigeminal neuralgia, or tic douloureux, can cause sudden, sporadic and debilitating burning or shock-like pain in the face or head. While rare — affecting only four to five out of 100,000 people — it affects more women than men and is more common in older adults. Patients of any age require a thorough workup since trigeminal neuralgia can be triggered by multiple sclerosis or a brain tumor.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Emad Estemalik, MD, Section Head of Headache and Facial Pain in Cleveland Clinic’s Center for Neurological Restoration, discusses the challenges of diagnosing and treating this condition in the latest episode of Cleveland Clinic’s Neuro Pathways podcast.

His brief audio interview highlights the following:

  • How to make a correct diagnosis — including the main differential
  • The importance of multidisciplinary care in determining treatment
  • Options for surgical treatment and when to consider them

Click the player below to listen to the podcast now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Estemalik: We always like to have patients first seen by one of our headache specialists or neurologists to ensure the accurate diagnosis has been made and the workup has been concluded. Patients should exhaust all pharmacological and procedural treatments before seeing a neurosurgeon. At a later point when, for instance, treatments are not working anymore, we discuss surgical approach.

The vast majority of patients do respond to the initial treatment, so that is good news. Some of the drugs that we use — like seizure medications, antidepressants and skeletal muscle relaxants — though they work, often have side effects. We try to work with the patient on the best medical option.

Then there are certain procedures that are very simple — like trigeminal nerve blocks and botulinum toxin injections — that also can provide pain relief. Our goal is to exhaust all these options before going to the next step, surgical intervention.

Advertisement

Again, we have a group of physicians, neurologists, headache specialists and surgeons who work closely together in setting the treatment plan.

The one thing we always tell our trigeminal neuralgia patients is that this is a chronic illness. We are not going to cure it right away, and it’s very, very likely that it’s always going to be there.

Advertisement

Related Articles

portrait of Dr. Imad Najm against decorative background with podcast overlay
September 2, 2026/Neurosciences/Podcast

Integrating AI Into EEG Evaluation and Epilepsy Care (Podcast)

Where the field is moving and what Cleveland Clinic has in the works

three health professionals standing in a futuristic operating room

8 Ways Our New Neurological Building Will Elevate Neurosurgical Practice

Expanded bevy of dedicated ORs will feature customized designs, leading-edge technology, optimized workflows

stock image of bionic-looking arm
August 26, 2026/Neurosciences/PM&R

Prosthetics Study Sheds Light on How the Brain Processes a Sense of Movement

Research could lead to bionic devices that work more like the human body

multicolored EEG wires plugged into an electrode junction box
August 13, 2026/Neurosciences/Epilepsy

Continuous EEG Is Key for Post-Stroke Epilepsy Risk Stratification in Selected Patients

Multicenter study offers guidance on when to consider extended monitoring

scan of a human brain

Study Links ANNA1/Hu-IgG Paraneoplastic Neurological Syndromes With Longer Cancer Survival

Findings may have implications for understanding the disorders’ pathophysiology

portait of Dr. Jay Alberts against decorative background with podcast icon overlay
July 16, 2026/Neurosciences/Podcast

Reshaping Research With Our New Neurological Assessment Center (Podcast)

Routine capture of standardized neuroperformance data may expand and refine investigations

woman looking concerned as she listens to a doctor speak to her

Study Offers First Characterization of Patients With Nonspecific Presentations of Multiple Sclerosis

Nearly one-fifth of such cases fulfill 2024 McDonald criteria based on biomarkers

gamma knife machine

Stereotactic Radiosurgery Shows Strong Local Control in SCLC Brain Metastases

Adequate dosing may improve outcomes in well-selected patients, large Cleveland Clinic series suggests

Ad